Table 1 Clinical characteristics of patients admitted to the study
From: Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity
Variable | The study group, GA genotype n = 140 | The control group GG genotype n = 150 | Statistical value | |||||
|---|---|---|---|---|---|---|---|---|
absolute number | (%) | absolute number | (%) | OR | 95%CI | p | ||
Age | 18–35 years old | 101 | 72.1 | 112 | 74.7 | 0.9 | 0.521–1.480 | 0.6268 |
> 35 years old | 39 | 27.9 | 38 | 25.3 | 1.1 | 0.675–1.917 | 0.6268 | |
Caucasian race | 130 | 92.9 | 138 | 92.0 | 1.1 | 0.472–2.705 | 0.7831 | |
BMI (kg/m2) | < 18.5 | 3 | 2.1 | 2 | 1.3 | 1.6 | 0.266–9.844 | 0.6 |
18.5–25 | 98 | 70.0 | 112 | 74.7 | 0.8 | 0.472–1.32 | 0.3747 | |
≥25 | 25 | 17.9 | 30 | 20.0 | 0.6 | 0.482–1.567 | 0.8696 | |
≥30 | 8 | 5.7 | 4 | 2.7 | 2.1 | 0.651–7.516 | 0.2033 | |
≥35 | 6 | 4.3 | 2 | 1.3 | 3.3 | 0.657–16.698 | 0.1466 | |
Hypertensive disease | 34 | 24.3 | 13 | 8.7 | 3.4 | 1.699–6.723 | 0.0005 | |